Continuous daily dosing of sunitinib in patients with metastatic renal cell cancer

Onkologie. 2008 Sep;31(8-9):432-3. doi: 10.1159/000144179. Epub 2008 Aug 12.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Comment

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Indoles / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / secondary*
  • Pyrroles / administration & dosage*
  • Sunitinib
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib